Lerosett High-content Organic Acne Treatment
NDC 58133-062
Product Information
Lerosett High-content Organic Acne Treatment is a OTC MONOGRAPH FINAL-approved product labeled by Cosmetic Specialty Labs, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 58133-062 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 58133-062?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SALICYLIC ACID (UNII: O414PZ4LPZ)
- SALICYLIC ACID (UNII: O414PZ4LPZ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALOE VERA LEAF (UNII: ZY81Z83H0X)
- CAPRYLYL GLYCOL (UNII: 00YIU5438U)
- COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
- COCO GLUCOSIDE (UNII: ICS790225B)
- GLYCERYL OLEATE (UNII: 4PC054V79P)
- LAURIC DIETHANOLAMIDE (UNII: I29I2VHG38)
- LAURYL GLUCOSIDE (UNII: 76LN7P7UCU)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- WATER (UNII: 059QF0KO0R)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- SODIUM LAURYL GLYCOL CARBOXYLATE (UNII: 8L0472VMYL)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1423838 - LEROSETT 2 % Medicated Liquid Soap
- RxCUI: 1423838 - salicylic acid 20 MG/ML Medicated Liquid Soap [LEROSETT]
- RxCUI: 1423838 - LEROSETT 20 MG/ML Medicated Liquid Soap
- RxCUI: 562600 - salicylic acid 2 % Medicated Liquid Soap
- RxCUI: 562600 - salicylic acid 20 MG/ML Medicated Liquid Soap
* Please review the full disclaimer at the bottom of this page.